| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -32.78M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, LRMR returned +6.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +9.7% |
| 1 year | +6.9% |
| 5 years | -71.0% |
| 10 years | -88.4% |
| All-time high | $475.32 (Mar 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in LRMR would be worth today ›No. Larimar Therapeutics, Inc. has not paid a dividend in the past 12 months.
Larimar Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol LRMR.
Larimar Therapeutics, Inc. is part of the Healthcare sector.
Larimar Therapeutics, Inc. has a market cap of 434.23M USD, based on the latest quote.
Larimar Therapeutics, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
